Colorectal Cancer (CRC) Clinical Trials in Nanchang, Jiangxi
5 recruitingNanchang, Jiangxi, China
Showing 1–5 of 5 trials
Recruiting
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751966
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751914
Recruiting
Not Applicable
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751940
Recruiting
Not Applicable
Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751953